Genedrive PLC - Manchester-based molecular diagnostics company - Enters into distribution agreements covering Spain, Portugal, Oman and the United Arab Emirates for its Covid-19 test kit. The company says these initial distributor arrangements are designed to access and assess the longer-term market potential in each country. Genedrive says end-user product evaluation in the UK is currently ongoing and Covid-19 test device approval is pending.
Current stock price: 17.79 pence, up 23% on Wednesday
12-month change: down 84%
By Heather Rydings; heatherrydings@alliancenews.com
Copyright 2022 Alliance News Limited. All Rights Reserved.
Genedrive (GDR)